Gregory Scott Duncan, CHIEF EXECUTIVE OFFICER at Virios Therapeutics, Inc. (VIRI), bought 5,000 shares at $5.52 ($28K) on 2021-12-21, disclosed to the SEC on 2021-12-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| VIRI | BUY | 2021-04-07 | $2K | — | Filing → |
| VIRI | BUY | 2021-04-06 | $193K | — | Filing → |